Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world.

Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform.

For more information please visit www.nicox.com

Kreos Capital

Nicox

Specializes in developing gene therapies for ocular diseases

SparingVision

Developer of ophthalmic drug design and delivery platform

Coave TX

Developer of gene therapies for eye diseases

Gyroscope

Specializes in ophthalmic drug design and delivery platform

Oculis

Pharmaceutical company focusing on dermatology and other therapeutic areas

Almirall

Specializes in medical devices and orthopedic products

Wright Medical Group

Biotechnology company focusing on immunotherapy

CEL-SCI

Develops therapies for blinding eye diseases

Clearside Biomedical

Biopharmaceutical company specializing in gene therapy and gene editing

IVERIC bio

Develops and commercializes ophthalmic products

EyePoint Pharmaceuticals

Biopharmaceutical company focusing on RNA interference technology

Dicerna Pharmaceuticals

Biopharmaceutical company focusing on rare diseases

Strongbridge Biopharma

Provides imaging services for clinical trials

Imaging Endpoints

Healthcare company specializing in pharmacy benefit management

Southern Scripts

Pharmaceutical company with a focus on gastrointestinal and CNS disorders

Alfasigma USA

Nicox S.A. is an international ophthalmology company specializing in the research, development, and commercialization of therapies for ocular diseases. The company focuses on both therapeutics and diagnostic tools to improve vision and eye health.

Cox Energy América, S.A.B. de C.V. engages in the management, development, and operation of portfolio of renewable energy projects in Europe and Latin America. It develops and operates photovoltaic solar assets. The company operates a portfolio of projects with a capacity of 1,808 MWh located in Mexico, Colombia, Latin America, Chile, Central America, and the Caribbean. It is also involved in the provision of project development, financing, asset management, energy supply, and operation and maintenance services. The company was founded in 2014 and is based in Mexico City, Mexico. Cox Energy América, S.A.B. de C.V. is a subsidiary of Cox Energy Solar S.A.

Cox Energy América, S.A.B. de C.V.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news impact assignment basic	general
public peers	general	Jun 22, 2024 8:46 AM	cdb41302
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 2:50 PM	8d773473
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	c5fdaf93
crunchbase profile	general
li profile	general	Jun 22, 2024 8:46 AM	936c82da
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 22, 2024 8:46 AM	480ebdda
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COX

COM:NICOX

Nicox S.A.

Last Close

1.56

22/10 14:00

Volume Today

255K

Avg: -